Grimes & Company, Inc. Innoviva, Inc. Transaction History

Grimes & Company, Inc.

$3.66 Billion
Q3 2024

A detailed history of Grimes & Company, Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, Grimes & Company, Inc. holds 11,897 shares of INVA stock, worth $209,982. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,897

Previous 11,897 -0.0%

Holding current value

$209,982

Previous $195,000 17.44%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$14.4 - $16.4 $1,195 - $1,361	83 Added 0.7%	11,897 $195,000
Q1 2024 Apr 17, 2024	SELL	$14.56 - $16.78 $4,149 - $4,782	-285 Reduced 2.36%	11,814 $180,000
Q4 2023 Jan 24, 2024	SELL	$12.32 - $16.27 $3,203 - $4,230	-260 Reduced 2.1%	12,099 $194,000
Q3 2023 Oct 19, 2023	BUY	$12.37 - $13.89 $1,818 - $2,041	147 Added 1.2%	12,359 $160,000
Q1 2023 Apr 20, 2023	BUY	$10.73 - $13.6 $11,566 - $14,660	1,078 Added 9.68%	12,212 $137,000
Q4 2022 Jan 25, 2023	SELL	$11.8 - $13.78 $1,191 - $1,391	-101 Reduced 0.9%	11,134 $0
Q3 2022 Oct 28, 2022	BUY	$11.61 - $15.22 $3,587 - $4,702	309 Added 2.83%	11,235 $130,000
Q2 2022 Jul 22, 2022	SELL	$14.32 - $19.88 $28,625 - $39,740	-1,999 Reduced 15.47%	10,926 $161,000
Q1 2022 May 06, 2022	BUY	$15.39 - $20.25 $18,544 - $24,401	1,205 Added 10.28%	12,925 $250,000
Q4 2021 Feb 01, 2022	SELL	$15.91 - $18.72 $4,311 - $5,073	-271 Reduced 2.26%	11,720 $202,000
Q3 2021 Nov 08, 2021	BUY	$13.06 - $17.24 $16,325 - $21,549	1,250 Added 11.64%	11,991 $200,000
Q2 2021 Aug 04, 2021	BUY	$11.45 - $13.96 $122,984 - $149,944	10,741 New	10,741 $144,000
Q2 2020 Jul 31, 2020	SELL	$11.49 - $15.26 $147,072 - $195,328	-12,800 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$8.11 - $15.23 $3,244 - $6,092	-400 Reduced 3.03%	12,800 $151,000
Q4 2019 Feb 05, 2020	BUY	$10.28 - $14.38 $135,696 - $189,816	13,200 New	13,200 $187,000

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.23B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Account

Grimes & Company, Inc. Innoviva, Inc. Transaction History